Pre-treatment blood levels of cell-free DNA fragments longer than 1650 base pairs predict early progression and progression-free survival in advanced cancer patients treated with immune checkpoint inhibitors.
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal –Anal Task Forces whitepaper
1 Pith paper cite this work, alongside 365 external citations. Polarity classification is still indexing.
1
Pith paper citing it
365
external citations · OpenAlex
citation-role summary
background 1
citation-polarity summary
fields
q-bio.QM 1years
2025 1verdicts
CONDITIONAL 1roles
background 1polarities
background 1representative citing papers
citing papers explorer
-
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors
Pre-treatment blood levels of cell-free DNA fragments longer than 1650 base pairs predict early progression and progression-free survival in advanced cancer patients treated with immune checkpoint inhibitors.